Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Liabilities and Shareholders Equity (2016 - 2025)

Nutex Health's Liabilities and Shareholders Equity history spans 16 years, with the latest figure at $918.5 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 40.16% year-over-year to $918.5 million; the TTM value through Dec 2025 reached $3.5 billion, up 81.51%, while the annual FY2025 figure was $918.5 million, 40.16% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $918.5 million at Nutex Health, down from $964.5 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $964.5 million in Q3 2025 and bottomed at $11.5 million in Q3 2021.
  • The 5-year median for Liabilities and Shareholders Equity is $431.8 million (2022), against an average of $475.9 million.
  • The largest annual shift saw Liabilities and Shareholders Equity surged 232242.53% in 2021 before it tumbled 49.36% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $394.7 million in 2021, then increased by 9.4% to $431.8 million in 2022, then fell by 7.76% to $398.2 million in 2023, then soared by 64.55% to $655.3 million in 2024, then soared by 40.16% to $918.5 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Liabilities and Shareholders Equity are $918.5 million (Q4 2025), $964.5 million (Q3 2025), and $841.0 million (Q2 2025).